SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Latest Comments
  • So simply put, we have the NABP saying that all ph... »
  • The original Brustle decision was widely criticise... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    欧洲审议WHO“无稽之谈”之际WHO筹备关于流感及病毒共享的新会议

    Published on 9 February 2010 @ 3:45 pm

    By and , Intellectual Property Watch

    通过世界卫生组织干事长的协调而进行的一个新的政府间谈判,将有望达成一项有关共享病毒材料及其收益与管理相关知识产权的协议。

    此前,通过上次政府间有关流行病准备工作会议和与干事长陈冯富珍进行非正式谈判的方式就这些问题取得共识证明结果并不明朗。

    同时,致力于促进人权和其他问题的欧洲理事会主办了一次有关世界卫生组织在流感大流行期间行为的公众听证会。

    新筹备的WHO会议将在5月17至22日WHO决策机构世界卫生大会之前的5月10至12日举行。此次会议是由WHO执行局于1月18至22日开会予以安排的,该局是世界卫生大会的咨询机构。

    各国政府同意,5月会议“应该以一种开放式工作组的模式举办,”并把提交给5月世界卫生大会的第一个政府间会议的最终报告作为基础文件。

    这一决定是通过澳大利亚、孟加拉、巴西、加拿大、中国、欧盟、法国、印度、印尼、日本、挪威、南非、瑞士、泰国、英国、美国和津巴布韦之间的非正式协商达成的。

    共享病毒,可这样有何好处?

    2009年的甲型H1N1流感发源于墨西哥,而墨西哥代表说,“尽管我们在共享病毒方面表现出善意”,而许多会议代表都把能如此迅速开发疫苗归功于此,“我们却从未从共享中获得任何益处。”

    “我们在市场中的疫苗数量有限,”这位墨西哥代表补充说,在墨西哥获得疫苗受到了限制,因此,他说,“我们就药品共享达成一项协议”十分关键。疫苗都是发达国家生产的。

    巴西强调,因为共享收益是成员国的权利,因此,任何此类协议都应该是“具有约束力和可以强制执行的”。

    国际药品制造者及协会联合会说,该联合会成员在研究、开发专有知识、疫苗用量以及通过在发展中国家分级定价以便降低成本方面自愿地作出了“前所未有的贡献”。第三世界网的桑吉塔•沙石康德(Sangeeta Shashikant)说,“很明显,发达国家散发疫苗而要求发展中国家依赖于诸如捐赠这样的临时性措施的体系是不公正的。”

    关于流行病的处理过程,各方也有一些评论。“我们希望世界卫生组织予以澄清,”印度代表说,该代表指的是有关世界卫生组织的咨询专家与医药业有关联的报道。“从公众认识角度讲,我们的工作遭到了质疑,”她 补充说,世界卫生组织必须出台一项声明。

    欧洲理事会的公众听证会

    世界卫生组织与欧洲制药业代表在斯特拉斯堡于1月26日举行的一个公众听证会上回答了来自理事会和新闻界有关其自去年夏天以来处理爆发流感不当的指责。

    宣布爆发流感是“一个不能得到任何证据支持的不可理喻的行为,”一位流行病专业医生、欧洲理事会的议会大会卫生问题分委会前主席沃尔夫冈•沃达格(Wolfgang Wodarg)说道。

    沃达格是欧洲理事会动议要求调查世界卫生组织带头签字人。他提出关切,去年6月份宣布流感爆发的目的主要是推动政府采购专利疫苗。沃达格呼吁开展调查,以确定这一“危险的无稽之谈”是如何发生的。

    但是,当前的流行病是“一个在科学界有据可查的事件,而非蓄意杜撰或凭空捏造之事,”由世界卫生组织总干事任命负责流行病工作的特别顾问福田敬二(Keiji Fukuda)反驳道。他补充指出,去年12月3日世界卫生组织网站贴出的一篇文章中说明了这一思路。

    欧洲疫苗制造商代表鲁克•赫赛尔(Luc Hessel)说,对那些关于疫苗制造如何运转“有着清醒认识的人来说,我们认为这一动议的内容是不妥当的。”他说,疫苗业者只是应决策者的要求从事。

    由世界卫生组织指定的明斯特大学(德国)流行病合作中心主任尤克里奇•基尔(Ukrich Keil)教授说,世界“正目睹公共卫生资源的巨大错配,”基尔说道,因为这一问题获得了远较其具有更大杀伤力的非流行疾病多得多的投资。

    参加听证的一位欧洲理事会议员反驳说,作为人民利益的捍卫者,他更趋向于采取谨慎的策略。“如果由于缺乏疫苗而造成一个人死亡,我们就会遭到批评,”他说,然后又补充道:“我并不持有医药公司的股票”。

    参加听证的一个议员批评了“世界卫生组织”对其结论“反应歇斯底里的方式”,“就好像它没有能力处理对该组织领导的质疑一样。一个像你们这样的组织认为自己无可指责、不受质疑,我对此感到反感。”

    福田敬二说,世界卫生组织“并没有幻想这是一个十全十美的反应。”但是,他说“当你面对一个胸口疼的病人时,你不会无所事事地等到这个人病情严重之后再做些什么 。。。我们采取了同一策略。”

    陈冯富珍向执行局宣布说,世界卫生组织将准备一份有关甲型H1N1流感全球反应审议报告的过渡稿,用于5月份举行的下一届世界卫生大会。

    在执行局做得开幕词中,她宣称流行病的温和性质是过去十年最好的卫生界新闻。她补充说,北半球或许已经度过了最糟糕的时刻,但是“冬天远未过去,”南半球即将进入流行季节。她补充说,对那些“关心获得流行病疫苗的”发展中国家来说,“世界卫生组织正积极推进其捐赠计划。”

    欲知更多详情,请参看:www.ip-watch.org

    劳玉军译

     


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

     

     
    Your IP address is 54.198.126.197